Google backs I/O start­up Ar­cus in $107M deal

Ar­cus Bio­sciences, with its in­trigu­ing can­cer pipeline and big shot CEO, has been a VC fa­vorite since its in­cep­tion in 2015. Now, Google’s ven­ture arm is back­ing the Bay Area start­up in a new $107 mil­lion round, bring­ing the com­pa­ny’s to­tal haul to a quar­ter bil­lion in start­up cap­i­tal in two years.

The lat­est in­fu­sion of cash was led by GV (for­mer­ly Google Ven­tures), with top-tier VC funds lin­ing up to join, in­clud­ing Welling­ton Man­age­ment Com­pa­ny, EcoR1 Cap­i­tal and oth­ers.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER